S-337395 powder for oral suspension clinical trials

Evaluate the efficacy, safety and dose-response of S-337395

This study tests a new medicine called S-337395 for treating Respiratory Syncytial Virus (RSV). Healthy volunteers aged 18-55 will be given RSV and then the study drug or a dummy drug to see if it works and is safe. The study takes place in London.